| 13183-79-4 | 5-Mercapto-1-Methyltetrazole | 864731-61-3 | Fluralaner | 68373-14-8 | Sulbactam acid |
| 173334-57-1 | Aliskiren | 54-31-9 | Furosemide | 76497-13-7 | Sultamicillin |
| 73547-70-3 | Ceftazidime dihydrochloride | 1369764-02-2 | Lemborexant | 89786-04-9 | Tazobactam acid |
| 113136-77-9 | Cyclanilide | 1138245-21-2 | Mirogabalin besylate | 2023788-19-2 | Tirzepatide |
| 211427-08-6 | Diquafosol tetrasodium | 186826-86-8 | Moxifloxacin hydrochloride | 1197-18-8 | Tranexamic acid |
| 1229194-11-9 | Edoxaban | 1192491-61-4 | NXL 104 | 2050057-56-0 | Upadacitinib |
| 1210344-83-4 | Ertugliflozin L-pyroglutamic acid | 144689-63-4 | Olmesartan Medoxomil | 1190389-15-1 | Vibegron |
| 1632006-28-0 | Esaxerenone | 93-10-7 | Quinaldic acid | 7078-98-0 |
2,6-bis(1,1-dimethylethyl)-4- (phenylmethylene)-2, 5-cyclohexadien-1-one |
| Biocatalysis | |||||
Vibegron (CAS 1190389-15-1) is a high-purity, GMP-compliant selective β3-adrenoceptor agonist API. It is clinically used for overactive bladder (OAB) to relieve urinary urgency, frequency and urge incontinence, with good cardiovascular safety profile. It conforms to USP, EP and ICH quality standards, suitable for oral pharmaceutical formulation R&D and commercial manufacturing.
Our hours
Monday to Friday
(8:30-17:30)